IM ELLIE EUNKYUNG (Chief Medical Officer) received a stock award from CRESCENT BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 12/17/2025ACC: 0001628280-25-057673
Officer· Chief Medical Officer
Since Jun 2025
+86.49K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
86.49K acquired
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+16.30K
Price / share
—
Trade value
—
% of position
New position
12/15/2025
0.00→16.30K
Ordinary Shares
Direct
Shares
+5K
Price / share
—
Trade value
—
% of position
30.7%
12/15/2025
16.30K→21.30K
Total
Net shares
+21.30K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 12/15/2025 | A · Award | +16.30K | — | — | New position | 0.00 | 16.30K |
| Ordinary Shares Direct | 12/15/2025 | A · Award | +5K | — | — | 30.7% | 16.30K | 21.30K |
| Total | +21.30K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Ordinary Shares
65.19K shares
Shares
+65.19K
Strike price
13.21
Held after
65.19K
Exercisable
—
12/15/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Ordinary Shares65.19K shares | 12/15/2025 | A · Award | +65.19K | 13.21 | — | 65.19K |